Revvity 19 may 2026 Revvity (RVTY) Is Down 5.0% After Raising 2026 Outlook And Securing FDA Assay Clearance - Sahm
Abbott 19 may 2026 Abbott Laboratories stock (US0028241000): steady momentum after latest earnings and diabetes tech pu - AD HOC NEWS
10x Genomics Blog 19 may 2026 10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
Vertex 19 may 2026 Vertex Pharma stock (US92532F1003): cystic fibrosis leader after solid quarterly results - AD HOC NEWS
Novo Nordisk 19 may 2026 BioStock launches Consensus Analysis – a new analytical format for Nordic life science - TradingView
Clinical OMICs 19 may 2026 FDA-Approved Asthma Drug Boosts Efficacy of Immunotherapy in Aggressive Cancers
10x Genomics Blog 19 may 2026 10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
Eli Lilly 19 may 2026 Supreme Court Ruling Puts Eli Lilly Medicaid Compliance And Investor Risks In Focus - simplywall.st
Labiotech 19 may 2026 Reducing cell culture contamination: Why sterilisation validation matters in CO₂ shaking workflows
Edwards Lifesciences 19 may 2026 Edwards Lifesciences stock (US28176E1082): heart-valve specialist in focus after latest earnings upd - AD HOC NEWS
Charles River 19 may 2026 Charles River Laboratories stock (US1591881009): Fresh earnings and outlook keep investors focused o - AD HOC NEWS
Lonza News 19 may 2026 Lonza Group AG stock (CH0013841017): pharma supplier in focus after 2025 results and dividend decisi - AD HOC NEWS
GCC 19 may 2026 Gamechangers: AI | CARMA’s Mazen Nahawi sees the GCC becoming a global laboratory for applied AI - MSN
LabCorp 19 may 2026 Labcorp stock (US50540R4092): Q1 results, new contracts and healthcare demand in focus - AD HOC NEWS
Qiagen 19 may 2026 Qiagen N.V. stock (NL0012169213): diagnostics specialist updates investors after Q1 results - AD HOC NEWS
Eurofins 19 may 2026 Eurofins Scientific SE stock (FR0014000MR3): Buyback activity puts focus on testing specialist - AD HOC NEWS